These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 33555529)

  • 21. miR-21 Inhibitors Modulate Biological Functions of Gastric Cancer Cells via PTEN/PI3K/mTOR Pathway.
    Wang P; Guan Q; Zhou D; Yu Z; Song Y; Qiu W
    DNA Cell Biol; 2018 Jan; 37(1):38-45. PubMed ID: 29185784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-221 induces cell survival and cisplatin resistance through PI3K/Akt pathway in human osteosarcoma.
    Zhao G; Cai C; Yang T; Qiu X; Liao B; Li W; Ji Z; Zhao J; Zhao H; Guo M; Ma Q; Xiao C; Fan Q; Ma B
    PLoS One; 2013; 8(1):e53906. PubMed ID: 23372675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-155-5p promotes tumor progression and contributes to paclitaxel resistance via TP53INP1 in human breast cancer.
    Li Y; Zhang L; Dong Z; Xu H; Yan L; Wang W; Yang Q; Chen C
    Pathol Res Pract; 2021 Apr; 220():153405. PubMed ID: 33756128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3β signaling pathway.
    Shen H; Li L; Yang S; Wang D; Zhong S; Zhao J; Tang J
    Gene; 2016 Nov; 593(1):84-90. PubMed ID: 27523474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol.
    Ren Y; Zhou X; Mei M; Yuan XB; Han L; Wang GX; Jia ZF; Xu P; Pu PY; Kang CS
    BMC Cancer; 2010 Jan; 10():27. PubMed ID: 20113523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of miR-4262 in paclitaxel resistance through the regulation of PTEN in non-small cell lung cancer.
    Sun H; Zhou X; Bao Y; Xiong G; Cui Y; Zhou H
    Open Biol; 2019 Jul; 9(7):180227. PubMed ID: 31337279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-425-5p promotes breast cancer cell growth by inducing PI3K/AKT signaling.
    Zhang LF; Zhang JG; Zhou H; Dai TT; Guo FB; Xu SY; Chen Y
    Kaohsiung J Med Sci; 2020 Apr; 36(4):250-256. PubMed ID: 31688991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway.
    Matà R; Palladino C; Nicolosi ML; Lo Presti AR; Malaguarnera R; Ragusa M; Sciortino D; Morrione A; Maggiolini M; Vella V; Belfiore A
    Oncotarget; 2016 Feb; 7(7):7683-700. PubMed ID: 26655502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Shikonin suppresses proliferation and induces apoptosis in endometrioid endometrial cancer cells via modulating
    Huang C; Hu G
    Biosci Rep; 2018 Apr; 38(2):. PubMed ID: 29449346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory role of large intergenic noncoding RNA-ROR on tamoxifen resistance in the endocrine therapy of breast cancer by regulating the PI3K/Akt/mTOR signaling pathway.
    Lu PW; Li L; Wang F; Gu YT
    J Cell Physiol; 2019 Feb; 234(2):1904-1912. PubMed ID: 30145819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer.
    Hu Y; Qiu Y; Yagüe E; Ji W; Liu J; Zhang J
    Cell Death Dis; 2016 Jun; 7(6):e2291. PubMed ID: 27362808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitory effects of everolimus in combination with paclitaxel on adriamycin-resistant breast cancer cell line MDA-MB-231.
    Xu T; Liu P; Li Q; Shi C; Wang X
    Taiwan J Obstet Gynecol; 2020 Nov; 59(6):828-834. PubMed ID: 33218396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The combined restoration of miR-424-5p and miR-142-3p effectively inhibits MCF-7 breast cancer cell line via modulating apoptosis, proliferation, colony formation, cell cycle and autophagy.
    Dastmalchi N; Safaralizadeh R; Khojasteh SMB; Shadbad MA; Hosseinpourfeizi MA; Azarbarzin S; Rajabi A; Baradaran B
    Mol Biol Rep; 2022 Sep; 49(9):8325-8335. PubMed ID: 35666424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-205-5p regulates epithelial-mesenchymal transition by targeting PTEN via PI3K/AKT signaling pathway in cisplatin-resistant nasopharyngeal carcinoma cells.
    Zhang P; Lu X; Shi Z; Li X; Zhang Y; Zhao S; Liu H
    Gene; 2019 Aug; 710():103-113. PubMed ID: 31158447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-21-5p enhances the progression and paclitaxel resistance in drug-resistant breast cancer cell lines by targeting PDCD4.
    Tao L; Wu YQ; Zhang SP
    Neoplasma; 2019 Sep; 66(5):746-755. PubMed ID: 31169019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of miR-129-5p increases the sensitivity to Taxol through inhibiting HMGB1-mediated cell autophagy in breast cancer MCF-7 cells.
    Shi Y; Gong W; Lu L; Wang Y; Ren J
    Braz J Med Biol Res; 2019; 52(11):e8657. PubMed ID: 31664305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-339-5p downregulation contributes to Taxol resistance in small-cell lung cancer by targeting α1,2-fucosyltransferase 1.
    Gan CZ; Li G; Luo QS; Li HM
    IUBMB Life; 2017 Nov; 69(11):841-849. PubMed ID: 28940895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-26a-5p enhances cells proliferation, invasion, and apoptosis resistance of fibroblast-like synoviocytes in rheumatoid arthritis by regulating PTEN/PI3K/AKT pathway.
    Huang Z; Xing S; Liu M; Deng W; Wang Y; Huang Z; Huang Y; Huang X; Wu C; Guo X; Pan X; Jiang J; Feng F; Li T
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31221815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-breast-Cancer Activity Exerted by β-Sitosterol-d-glucoside from Sweet Potato via Upregulation of MicroRNA-10a and via the PI3K-Akt Signaling Pathway.
    Xu H; Li Y; Han B; Li Z; Wang B; Jiang P; Zhang J; Ma W; Zhou D; Li X; Ye X
    J Agric Food Chem; 2018 Sep; 66(37):9704-9718. PubMed ID: 30160115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-30e inhibits tumor growth and chemoresistance via targeting IRS1 in Breast Cancer.
    Liu MM; Li Z; Han XD; Shi JH; Tu DY; Song W; Zhang J; Qiu XL; Ren Y; Zhen LL
    Sci Rep; 2017 Nov; 7(1):15929. PubMed ID: 29162879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.